This inventor holds 1 USPTO granted patent. Top assignee: Haemacure Biotech Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Innovations of Dominique Michel St Picq
Introduction
Dominique Michel St Picq is a notable inventor based in Ste-Genevieve, CA. He has made significant contributions to the field of biotechnology, particularly in the development of biological adhesives. His innovative approach has led to the creation of a unique process that enhances the efficacy of coagulation proteins.
Latest Patents
Dominique holds a patent for a process for the obtention of a biological adhesive made of concentrated coagulation proteins. This invention relates to a method of producing a concentrate from whole human or animal plasma. The resulting concentrate is utilized as a biological adhesive when mixed with thrombin. The process is advantageous due to its efficiency and high yield of coagulable proteins, which include fibrinogen, fibrin stabilizing factor (factor XIII), and fibronectin. Notably, no protease inhibitors are required during the process, and the proteins obtained are stable for at least 24 hours after reconstitution in water.
Career Highlights
Dominique is associated with Haemacure Biotech Inc., where he applies his expertise in biotechnology to advance medical applications. His work focuses on improving the quality and effectiveness of biological adhesives, which have significant implications in medical procedures.
Collaborations
Dominique has collaborated with notable colleagues, including Trung Bui-Khac and Lise Lavoie. Their combined efforts contribute to the innovative research and development within the company.
Conclusion
Dominique Michel St Picq's contributions to the field of biotechnology through his patented process for biological adhesives demonstrate his commitment to innovation. His work not only enhances medical practices but also showcases the potential of coagulation proteins in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile